A|I: The AI Times – Samsung values Toronto’s Tenstorrent at $2 billion
Plus: Why Big Tech launches unreliable AI apps.
As Collision kicks off, four Canadian tech startups unveil new funding
Heylist, Vosyn, Pok Pok, and Ability Biologics have all raised fresh capital.
TD Bank launches Innovation Partners banking platform for tech companies
TD Innovation Partners’ leadership team is almost entirely ex-SVB and ex-RBCx leaders.
Chexy secures $4.1 million to improve its rent-to-rewards platform’s payments infrastructure
Chexy is looking to become a one-stop shop for tenants paying their monthly rent and expenses.
S|W: The SaaS Weekly – Regulations? Uber can “suck it up,” says BC premier
Plus: Copperleaf to go private in billion-dollar deal.
F|T: The FinTech Times – Brex drops a CEO and looks to IPO
Plus: An exclusive interview on the new Float product launches.
Borderless AI makes its Cohere-powered HR agent free to use
As part of the Cohere Startup Program, Borderless hopes to attract new customers by opening up its AI offering.
H|T: The Healthtech Times – Acorn Biolabs secures $11 million for regenerative medicine
Plus: Feds table bill with new healthtech data security rules.
Northleaf and Kensington both close their VCCI-backed funds
VCCI-backed funds-of-funds feature respective $370 million and $290 million war chests.
R|T: The Retail Times – Exclusive: Ex-Lightspeed CEO nabs Inovia gig
Plus: Costco building an ad business with customer data.
Descartes acquires UK-based logistics platform BoxTop for $18 million CAD
The deal follows a similar across-the-pond acquisition in April.
Zero Point Cryogenics secures $2.67 million to help cool quantum computers
The non-dilutive funding came from PrairiesCan and the City of Edmonton’s Edge Fund.
Sharethrough to merge with French adtech firm Equativ
Deal comes two-and-a-half years after Sharethrough scrapped TSX IPO plans.
A|I: The AI Times – Cohere had a busy week
Plus: How Apple fell behind in the AI arms race.
Kardium secures $143 million CAD to help bring irregular heartbeat treatment to market
The financing follows Kardium’s $158-million CAD round in 2021.